Isthmus Partners LLC Has $15.15 Million Holdings in Procter & Gamble Company (The) $PG

Isthmus Partners LLC lifted its position in shares of Procter & Gamble Company (The) (NYSE:PG) by 860.1% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 98,617 shares of the company’s stock after acquiring an additional 88,346 shares during the period. Procter & Gamble comprises approximately 3.4% of Isthmus Partners LLC’s holdings, making the stock its 6th largest holding. Isthmus Partners LLC’s holdings in Procter & Gamble were worth $15,153,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in the business. Czech National Bank increased its stake in shares of Procter & Gamble by 3.8% in the third quarter. Czech National Bank now owns 594,914 shares of the company’s stock valued at $91,409,000 after purchasing an additional 21,825 shares during the period. Westerkirk Capital Inc. bought a new position in Procter & Gamble in the 2nd quarter worth approximately $4,796,000. Vega Investment Solutions increased its position in Procter & Gamble by 1.3% in the 2nd quarter. Vega Investment Solutions now owns 638,400 shares of the company’s stock valued at $101,710,000 after acquiring an additional 8,500 shares during the period. Jump Financial LLC bought a new stake in Procter & Gamble during the 2nd quarter valued at $7,891,000. Finally, SVB Wealth LLC acquired a new position in Procter & Gamble during the 2nd quarter worth $12,725,000. Institutional investors and hedge funds own 65.77% of the company’s stock.

Insider Activity at Procter & Gamble

In related news, insider Moses Victor Javier Aguilar sold 15,169 shares of the company’s stock in a transaction that occurred on Friday, February 13th. The shares were sold at an average price of $162.28, for a total value of $2,461,625.32. Following the completion of the sale, the insider owned 44,735 shares in the company, valued at approximately $7,259,595.80. This represents a 25.32% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Chairman Jon R. Moeller sold 162,232 shares of Procter & Gamble stock in a transaction that occurred on Thursday, February 12th. The stock was sold at an average price of $162.45, for a total transaction of $26,354,588.40. Following the transaction, the chairman owned 319,385 shares in the company, valued at approximately $51,884,093.25. The trade was a 33.68% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 341,260 shares of company stock valued at $54,256,985. Corporate insiders own 0.20% of the company’s stock.

Procter & Gamble Trading Up 1.4%

Procter & Gamble stock opened at $160.77 on Friday. Procter & Gamble Company has a 1 year low of $137.62 and a 1 year high of $179.99. The firm’s 50 day moving average price is $149.02 and its two-hundred day moving average price is $150.70. The firm has a market cap of $373.62 billion, a price-to-earnings ratio of 23.82, a price-to-earnings-growth ratio of 5.27 and a beta of 0.38. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.51 and a current ratio of 0.72.

Procter & Gamble (NYSE:PG) last released its quarterly earnings data on Thursday, January 22nd. The company reported $1.88 earnings per share for the quarter, topping the consensus estimate of $1.86 by $0.02. The business had revenue of $22.21 billion during the quarter, compared to analyst estimates of $22.36 billion. Procter & Gamble had a return on equity of 32.21% and a net margin of 19.30%.The company’s revenue was up 1.5% compared to the same quarter last year. During the same period last year, the company posted $1.88 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, research analysts predict that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, February 17th. Shareholders of record on Friday, January 23rd were issued a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a yield of 2.6%. The ex-dividend date was Friday, January 23rd. Procter & Gamble’s payout ratio is presently 62.67%.

Analyst Ratings Changes

A number of brokerages recently weighed in on PG. Wells Fargo & Company restated an “overweight” rating and set a $177.00 price objective on shares of Procter & Gamble in a research note on Tuesday. Weiss Ratings reissued a “hold (c)” rating on shares of Procter & Gamble in a research note on Monday, December 29th. Erste Group Bank raised shares of Procter & Gamble from a “hold” rating to a “buy” rating in a research note on Wednesday. TD Cowen lowered shares of Procter & Gamble from a “buy” rating to a “hold” rating and raised their price objective for the company from $150.00 to $156.00 in a research note on Tuesday, January 27th. Finally, Dbs Bank raised Procter & Gamble from a “hold” rating to a “buy” rating in a report on Friday, January 23rd. Fourteen analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $168.33.

Procter & Gamble Profile

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.